STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
CLRB CELLECTAR BIOSCIENCES INCORPORATED StockScouter® Report
8
StockScouter® Score
CELLECTAR BIOSCIENCES INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The multi-period measure of relative price change and consistency is well above average. Positive
- Moving average analysis for CLRB suggests strong price movement over the medium term. Positive
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
Concerns
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
C
N/A
A